CHISON MEDICAL(SH:688358) Sou Hu Cai Jing·2025-11-21 00:44Core Viewpoint - Xiangsheng Medical (688358) experienced a decline in stock price, closing at 31.97 yuan on November 20, 2025, down 2.65% with a trading volume of 11,400 shares and a turnover of 36.96 million yuan [1] Group 1: Financial Performance - For the first three quarters of 2025, the company's main revenue was 343 million yuan, a year-on-year decrease of 5.27% [5] - The net profit attributable to shareholders was 93.92 million yuan, down 4.56% year-on-year [5] - The third quarter of 2025 saw a single-quarter main revenue of 107 million yuan, a year-on-year decrease of 6.68%, while the single-quarter net profit attributable to shareholders increased by 41.95% to 24.22 million yuan [5] Group 2: Market Activity - On November 20, 2025, the net outflow of main funds was 7.28 million yuan, accounting for 19.7% of the total turnover [1][2] - Retail investors had a net inflow of 3.74 million yuan, representing 10.12% of the total turnover on the same day [1][2] - The financing balance on November 20, 2025, was 93.99 million yuan, with a net financing purchase of 1.13 million yuan [3] Group 3: Industry Comparison - Xiangsheng Medical's total market value is 3.585 billion yuan, compared to the industry average of 11.144 billion yuan, ranking 93rd in the industry [5] - The company's price-to-earnings ratio (P/E) is 28.62, significantly lower than the industry average of 55.37, ranking 28th in the industry [5] - The gross profit margin of Xiangsheng Medical is 59.82%, higher than the industry average of 51.22%, ranking 52nd in the industry [5]